Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MP-513 in type 2 diabetes
NCT01072331Phase 3Completed
- Sponsor
- Mitsubishi Tanabe Pharma
- Start
- Feb 2010
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of teneligliptin in type 2 diabetes mellitus (T2DM), sponsored by Mitsubishi Tanabe Pharma. Started Feb 2010; status: completed.
02
Drugs
teneligliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01072331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01072331.